Cipla in focus after partnership with MannKind
Most Popular (6 hours)

Hyundai inks pact with Revv India

- centralchronicle.com/

Most Popular (24 hours)

Japan Nikkei falls 0.25%

- business-standard

The two uncles

- business-standard

Most Popular (a week)

business-standard
3 months ago

Cipla in focus after partnership with MannKind

Cipla announced that it has entered into an exclusive marketing and distribution agreement with US-based MannKind Corporation for Afrezza in India. Afrezza is the only USFDA approved inhaled insulin available for patients suffering from diabetes. The anno

Read on the original site


Five gamblers nabbed

- news.statetimes.in

Shopkeepers resent MC drive

- news.statetimes.in

Parliwand deputation calls on DC

- news.statetimes.in

Three arrested with heroin

- news.statetimes.in
Hashtags:   

Cipla

 | 

focus

 | 

after

 | 

partnership

 | 

with

 | 

MannKind

 |